Good MorningEquity markets moved on Thursday, but it may be another top in a frothy market. The latest rally is driven by hopes the banking crisis is already behind us despite the fact the FOMC is on track to hike rates 1 more time this year. The risk for traders is that PCE data release will be hot or hotter than expected and keep the Fed hiking until later in the year.
If the market can not move higher today, it will confirm resistance for the 3rd time this year. Such a move would keep the S&P 500 rage bound until the 2nd half, when there is an expectation for earnings growth. Until then, investors should stick to their investment plans and use market dips to load up on their favorite stocks. Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Technology | |
Paychex, Inc. (NASDAQ: PAYX) isn’t a value stock but offers value and yield to investors. Trading at 27X its earnings, it is fairly valued compared to peer Automatic Data Processing (NYSE: ADP) and pays a significantly higher yield. The stock delivers a 2.75% yield, with shares trading near ... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Auto/Tires/Trucks | |
If you’ve been watching the short interest in EVGo (NYSE: EVGO) and wondering when and if a squeeze will happen, it is. The company’s q4 results and outlook affirm the business potential and have the stock up 25%. That is a significant move driven by short-covering that confirms suppor... Read the Full Story |
|
Consumer Staples | |
Signs within the RH (NYSE: RH) report indicate that a bottom could be in play for the stock. While results are worse than the Marketbeat.com consensus figures and the guidance is poor, there is an expectation for margin improvement throughout the year. The company is doubling-down on restructuring... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Basic Materials | |
Dividend King H.B. Fuller (NYSE: FUL) is not an exciting stock but can be a telling indicator of economic activity. The company makes glue and adhesives for all end market uses, a leading input for all industries. The company’s results don’t point to dividend cuts or suspensions but su... Read the Full Story |
|
Finance | |
Every investor knows that “let the buyer beware” is always sound advice. And when you throw in a global banking crisis, that should make investors very cautious. In the midst of this, it can be easy to overlook a small-cap stock like SoFi Technologies, Inc. (NASDAQ: SOFI). The company ... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Retail/Wholesale | |
Dividend stocks come in many shapes and sizes. Large caps and small caps. Quarterly and monthly payers. High yield. Dividend growers.
And then there are dividend initiators.
The newbies of the dividend world are companies that are returning cash to shareholders for the first time. They can also... Read the Full Story |
|
Industrials | |
Unifirst (NYSE: UNF) is fast becoming the next Cintas (NASDAQ: CTAS), which matters for several reasons. Competition for Cintas aside, Cintas is a blue-chip business services company with robust cash flows, a healthy dividend, a long history of dividend growth, the ability to grow business without... Read the Full Story |
|
Technology | |
Oppenheimer and Raymond James financial analysts upgraded Ciena Corp.'s (NYSE: CIEN) rating from Outperform to Strong Buy this week. The sentiment bump also helped push share value up by 3.1% on the news, coincidentally raising the price target from $58 to $70. It is a bold shift since at least 4 ... Read the Full Story |
|
Retail/Wholesale | |
The Chinese equity market has been out of favor since the United States decided to stimulate the economy with newly printed dollar bills and rock-bottom interest rates as a way to pull the nation out of the slump brought on by the COVID-19 pandemic. While the American equity market has received al... Read the Full Story |
|
Consumer Staples | |
Monster Beverage Corp. (NASDAQ: MNST) is holding steady in a flat base with an 8% correction, after hitting resistance at $52.75, following a 2-for-1 stock split. The stock began trading on an adjusted basis on March 28, but that didn't affect the chart pattern that’s forming.
To see how M... Read the Full Story |
|
Friday's Early Bird Stock Of The Day 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California. | | View Today's Stock Pick |
|
